<div id="readability-page-1"><p><span>Molina Healthcare (NYSE:MOH - Get Free Report)</span> had its price objective boosted by investment analysts at JPMorgan Chase &amp; Co.  from $169.00 to $191.00 in a report released on Monday,Benzinga reports. The brokerage currently has a &#34;neutral&#34; rating on the stock. JPMorgan Chase &amp; Co.'s target price suggests a potential downside of 3.13% from the company's current price.</p><div><p><span></span><span>Get <strong>Molina Healthcare</strong> alerts:</span></p></div><ul><li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li></ul><p>Other research analysts have also recently issued reports about the stock. Barclays increased their price target on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an &#34;underweight&#34; rating in a research report on Tuesday, May 26th. UBS Group raised their price target on Molina Healthcare from $180.00 to $202.00 and gave the company a &#34;neutral&#34; rating in a report on Friday, May 22nd. TD Cowen reduced their price target on Molina Healthcare from $175.00 to $144.00 and set a &#34;hold&#34; rating for the company in a report on Monday, February 9th. Wells Fargo &amp; Company raised their price target on Molina Healthcare from $141.00 to $159.00 and gave the company an &#34;equal weight&#34; rating in a report on Monday, April 27th. Finally, Truist Financial raised their price target on Molina Healthcare from $180.00 to $205.00 and gave the company a &#34;hold&#34; rating in a report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned  a Hold rating and two have issued  a Sell rating to the company's stock. Based on data from MarketBeat, Molina Healthcare presently has an average rating of &#34;Hold&#34; and a consensus target price of $182.73.</p><p><b>View Our Latest Analysis on Molina Healthcare</b></p><h2>Molina Healthcare Trading Up 3.3%</h2><ul><li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li></ul><p>NYSE MOH traded up $6.31 during trading hours on Monday, reaching $197.17. The company's stock had a trading volume of 159,551 shares, compared to its average volume of 1,567,760. The stock has a market cap of $10.27 billion, a P/E ratio of 58.26 and a beta of 0.80. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $311.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The firm has a fifty day simple moving average of $168.40 and a 200-day simple moving average of $162.57. </p><p>Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter last year, the firm posted $6.08 EPS. The company's quarterly revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS.  Equities analysts forecast that  Molina Healthcare will post 5.23 earnings per share for the current fiscal year. </p><h2>Insider Activity</h2><ul><li>3 Health Insurance Stocks Holding Green in Market Turmoil</li></ul><p>In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the firm's stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares of the company's stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the firm's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own  1.44% of the company's stock. </p><h2>Institutional Trading of Molina Healthcare</h2><p>Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Torren Management LLC bought a new position in  Molina Healthcare in the 4th quarter valued at $26,000.  Miller Global Investments LLC bought a new position in  Molina Healthcare in the 4th quarter valued at $27,000.  MUFG Securities EMEA plc bought a new position in  Molina Healthcare in the 2nd quarter valued at $48,000.  Cromwell Holdings LLC grew its position in  Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company's stock valued at $32,000 after acquiring an additional 125 shares during the last quarter.  Finally, Quarry LP bought a new position in  Molina Healthcare in the 4th quarter valued at $32,000. Hedge funds and other institutional investors own  98.50% of the company's stock. </p><h2>About Molina Healthcare</h2> (Get Free Report)<p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.  </p><p>The company traces its roots to the early 1980s, when Dr.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Molina Healthcare</li><li>Nebius Is Up Nearly 175% This Year—Here's What's Driving the Latest Run</li><li>Technology Stocks Just Got Cheaper—Here Are 5 Mega-Caps Worth a Closer Look</li><li>3 Energy Stocks Built for the AI Power Boom—And Beyond</li><li>Allstate’s Comeback Is Turning Into a Profit Machine</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2><p>Before you consider Molina Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BARC

<p>JPMorgan Chase raised its price target for Molina Healthcare (NYSE:MOH) from $169.00 to $191.00, maintaining a 'neutral' rating. Other analysts also adjusted targets: Barclays increased to $199.00 ('underweight'), UBS to $202.00 ('neutral'), and Truist to $205.00 ('hold'). Conversely, TD Cowen lowered its target to $144.00 ('hold'). The consensus rating remains 'Hold' with an average target of $182.73.</p>

Market Beat

Molina Healthcare

Barclays

UBS Group AG

JPMorgan Chase

Toronto Dominion Bank

Wells Fargo

Truist Financial

Centene

Mitsubishi UFJ Financial Group, Inc.

Mitsubishi UFJ Financial

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

JPMorgan Chase & Co. Issues Positive Forecast for Molina Healthcare (NYSE:MOH) Stock Price